Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO …
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO … 
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection.
The International Psoriasis Council has divided psoriasis treatment classification into 2 groups:
Patients who are a candidate for topical therapy, or
Patients who are a candidate for systemic therapy
Candidates for systemic therapy must meet at least 1 of the following … 
Dr. Vishal Patel (Assistant Professor of Dermatology and Director of the Cutaneous Oncology Program at George Washington University School of Medicine and Health Sciences) gave a thought-provoking talk at the 2022 ODAC Dermatology, Aesthetic & Surgical Conference about something we do nearly every day as dermatologists – full body skin exams. He started by reviewing the rising epidemic of sk … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about why a "mean" approach is most effective when treating warts. Watc … 
Hair loss can be such a challenging disease to treat, especially with the social toll it can take on patients. Do you struggle to keep up with the newest treatments and data on hair loss? If so, keep reading as we learn from Dr. Shilpi Khetarpal, Associate Professor of Dermatology and Director of Cosmetic Dermatology and Lasers at Cleveland Clinic, about adjunctive therapies for hair loss based on … 